Showing results 1 to 20 of 60
next >
| Issue Date | Title | Author(s) |
| 2021-05 | Current-status and applications of polysaccharides in drug delivery systems | Prasher, P; Sharma, M; Mehta, M; Satija, S; Aljabali, AA; Tambuwala, MM; Anand, K; Sharma, N; Dureja, H; Jha, NK; Gupta, G; Gulati, M; Singh, SK; Chellappan, DK; Paudel, KR; Hansbro, PM; Dua, K |
| 2021-03 | Rutin loaded liquid crystalline nanoparticles inhibit non-small cell lung cancer proliferation and migration in vitro | Paudel, KR; Wadhwa, R; Tew, XN; Lau, NJX; Madheswaran, T; Panneerselvam, J; Zeeshan, F; Kumar, P; Gupta, G; Anand, K; Singh, SK; Jha, NK; MacLoughlin, R; Hansbro, NG; Liu, G; Shukla, SD; Mehta, M; Hansbro, PM; Chellappan, DK; Dua, K |
| 2021-02-04 | Rutin-loaded liquid crystalline nanoparticles attenuate oxidative stress in bronchial epithelial cells: a PCR validation. | Mehta, M; Paudel, KR; Shukla, SD; Shastri, MD; Satija, S; Singh, SK; Gulati, M; Dureja, H; Zacconi, FC; Hansbro, PM; Chellappan, DK; Dua, K |
| 2020-12-01 | Overcoming the dissolution rate, gastrointestinal permeability and oral bioavailability of glimepiride and simvastatin co-delivered in the form of nanosuspension and solid self-nanoemulsifying drug delivery system: A comparative study | Pandey, NK; Singh, SK; Gulati, M; Kumar, B; Kapoor, B; Ghosh, D; Kumar, R; Khursheed, R; Awasthi, A; Kuppusamy, G; Wadhwa, S; Satija, S; Dureja, H; Jain, SK; Chellappan, DK; Anand, K; Mehta, M; Dua, K |
| 2020-12-01 | Development of modified apple polysaccharide capped silver nanoparticles loaded with mesalamine for effective treatment of ulcerative colitis | Kaur, G; Singh, SK; Kumar, R; Kumar, B; Kumari, Y; Gulati, M; Pandey, NK; Gowthamarajan, K; Ghosh, D; Clarisse, A; Wadhwa, S; Mehta, M; Satija, S; Dua, K; Dureja, H; Gupta, S; Singh, PK; Kapoor, B; Chitranshi, N; Kumar, A; Porwal, O |
| 2020-11-30 | Correction: Aljabali, A.A.A.; et al. Albumin Nano-Encapsulation of Piceatannol Enhances Its Anticancer Potential in Colon Cancer via down Regulation of Nuclear p65 and HIF-1α. Cancers 2020, 12, 113. | Aljabali, AAA; Bakshi, HA; Hakkim, FL; Haggag, YA; Al-Batanyeh, KM; Zoubi, MSA; Al-Trad, B; Nasef, MM; Satija, S; Mehta, M; Pabreja, K; Mishra, V; Khan, M; Abobaker, S; Azzouz, IM; Dureja, H; Pabari, RM; Dardouri, AAK; Kesharwani, P; Gupta, G; Dhar Shukla, S; Prasher, P; Charbe, NB; Negi, P; Kapoor, DN; Chellappan, DK; Webba da Silva, M; Thompson, P; Dua, K; McCarron, P; Tambuwala, MM |
| 2020-11-30 | Curcumin-loaded niosomes downregulate mRNA expression of pro-inflammatory markers involved in asthma: an in vitro study. | Jin-Ying Wong; Yin Ng, Z; Mehta, M; Shukla, SD; Panneerselvam, J; Madheswaran, T; Gupta, G; Negi, P; Kumar, P; Pillay, V; Hsu, A; Hansbro, NG; Wark, P; Bebawy, M; Hansbro, PM; Dua, K; Chellappan, DK |
| 2020-11-29 | Anti-inflammatory and anticancer activities of Naringenin-loaded liquid crystalline nanoparticles in vitro. | Wadhwa, R; Paudel, KR; Chin, LH; Hon, CM; Madheswaran, T; Gupta, G; Panneerselvam, J; Lakshmi, T; Singh, SK; Gulati, M; Dureja, H; Hsu, A; Mehta, M; Anand, K; Devkota, HP; Chellian, J; Chellappan, DK; Hansbro, PM; Dua, K |
| 2020-11-16 | Advancing of Cellular Signaling Pathways in Respiratory Diseases Using Nanocarrier based Drug Delivery Systems. | Mehta, M; Dhanjal, DS; Satija, S; Wadhwa, R; Paudel, KR; Chellappan, DK; Mohammad, S; Haghi, M; Hansbro, PM; Dua, K |
| 2020-11-06 | Potential Anti-epileptic Phytoconstituents: An Updated Review. | Kaur, J; Famta, P; Famta, M; Mehta, M; Satija, S; Sharma, N; Vyas, M; Khatik, GL; Chellappan, DK; Dua, K; Khurana, N |
| 2020-11-04 | Interferon therapy for preventing COPD exacerbations | Mehta, M; Paudel, KR; Shukla, SD; Shastri, M; Singh, SK; Gulati, M; Dureja, H; Gupta, G; Satija, S; Hansbro, PM; Chellappan, DK; Dua, K |
| 2020-11-01 | Advanced drug delivery systems can assist in managing influenza virus infection: A hypothesis | Chan, Y; Ng, SW; Mehta, M; Anand, K; Kumar Singh, S; Gupta, G; Chellappan, DK; Dua, K |
| 2020-11 | Advanced drug delivery systems can assist in targeting coronavirus disease (COVID-19): A hypothesis | Mehta, M; Prasher, P; Sharma, M; Shastri, MD; Khurana, N; Vyas, M; Dureja, H; Gupta, G; Anand, K; Satija, S; Chellappan, DK; Dua, K |
| 2020-10-30 | Antiproliferative effects of boswellic acids-loaded chitosan nanoparticles on human lung cancer cell line A549. | Solanki, N; Mehta, M; Chellappan, DK; Gupta, G; Hansbro, NG; Tambuwala, MM; Aa Aljabali, A; Paudel, KR; Liu, G; Satija, S; Hansbro, PM; Dua, K; Dureja, H |
| 2020-10-15 | Sugar-based nanoparticles for respiratory diseases: a new paradigm in the nanoworld. | Chan, Y; Ng, SW; Mehta, M; Gupta, G; Chellappan, DK; Dua, K |
| 2020-10-10 | Solid lipid nanoparticles containing anti-tubercular drugs attenuate the Mycobacterium marinum infection. | Khatak, S; Mehta, M; Awasthi, R; Paudel, KR; Singh, SK; Gulati, M; Hansbro, NG; Hansbro, PM; Dua, K; Dureja, H |
| 2020-10-05 | Targeting interleukins in chronic airway diseases using advanced drug delivery. | Satija, S; Mehta, M; Gupta, G; Chellappan, DK; Dua, K |
| 2020-09-24 | Targeting respiratory diseases using miRNA inhibitor based nanotherapeutics: Current status and future perspectives. | Mehta, M; Satija, S; Paudel, KR; Malyla, V; Kannaujiya, VK; Chellappan, DK; Bebawy, M; Hansbro, PM; Wich, PR; Dua, K |
| 2020-09-01 | Emerging trends of liquid crystalline nanoparticles drug delivery for pulmonary disorders | Singh, VP; Mehta, M; Satija, S; Sharma, DS; Sharma, PK |
| 2020-09 | Vesicular drug delivery systems as theranostics in COVID-19. | Satija, S; Mehta, M; Sharma, M; Prasher, P; Gupta, G; Chellappan, DK; Dua, K |
